Saravana Kumar Jaganathan

Antiproliferative effects of honey and of its polyphenols: a review.

Honey has been used since long time both in medical and domestic needs, but only recently the antioxidant property of it came to limelight. The fact that antioxidants have several preventative effects against different diseases, such as cancer, coronary diseases, inflammatory disorders, neurological degeneration, and aging, led to search for food rich in antioxidants. Chemoprevention uses various dietary agents rich in phytochemicals which serve as antioxidants. With increasing demand for antioxidant supply in the food, honey had gained vitality since it is rich in phenolic compounds and other antioxidants like ascorbic acid, amino acids, and proteins. Some simple and polyphenols found in honey, namely, caffeic acid (CA), caffeic acid phenyl esters (CAPE), Chrysin (CR), Galangin (GA), Quercetin (QU), Kaempferol (KP), Acacetin (AC), Pinocembrin (PC), Pinobanksin (PB), and Apigenin (AP), have evolved as promising pharmacological agents in treatment of cancer. In this review, we reviewed the antiproliferative and molecular mechanisms of honey and above-mentioned polyphenols in various cancer cell lines.

Antiproliferative and molecular mechanism of eugenol-induced apoptosis in cancer cells.

Phenolic phytochemicals are a broad class of nutraceuticals found in plants which have been extensively researched by scientists for their health-promoting potential. One such a compound which has been comprehensively used is eugenol (4-allyl-2-methoxyphenol), which is the active component of Syzigium aromaticum (cloves). Aromatic plants like nutmeg, basil, cinnamon and bay leaves also contain eugenol. Eugenol has a wide range of applications like perfumeries, flavorings, essential oils and in medicine as a local antiseptic and anesthetic. Increasing volumes of literature showed eugenol possesses antioxidant, antimutagenic, antigenotoxic, anti-inflammatory and anticancer properties. Molecular mechanism of eugenol-induced apoptosis in melanoma, skin tumors, osteosarcoma, leukemia, gastric and mast cells has been well documented. This review article will highlight the antiproliferative activity and molecular mechanism of the eugenol induced apoptosis against the cancer cells and animal models.

Apoptotic effect of eugenol in human colon cancer cell lines

Eugenol, a natural compound available in honey and various plants extracts including cloves and Magnoliae flos, is exploited for various medicinal applications. Since most of the drugs used in the cancer are apoptotic inducers, the apoptotic effect and anticancer mechanism of eugenol were investigated against colon cancer cells. Antiproliferative effect was estimated using MTT [3‐(4,5‐dimethylthiazol‐2‐yl)‐2,5‐diphenyl tetrazolium bromide assay]. Earlier events like MMP (mitochondrial membrane potential), thiol depletion and lipid layer break were measured by using flow cytometry. Apoptosis was evaluated using PI (propidium iodide) staining, TUNEL (terminal deoxynucleotidyl transferase‐mediated dUTP nick end labelling) assay and DNA fragmentation assay. MTT assay signified the antiproliferative nature of eugenol against the tested colon cancer cells. PI staining indicated increasing accumulation of cells at sub‐G1‐phase. Eugenol treatment resulted in reduction of intracellular non‐protein thiols and increase in the earlier lipid layer break. Further events like dissipation of MMP and generation of ROS (reactive oxygen species) were accompanied in the eugenol‐induced apoptosis. Augmented ROS generation resulted in the DNA fragmentation of treated cells as shown by DNA fragmentation and TUNEL assay. Further activation of PARP (polyadenosine diphosphate‐ribose polymerase), p53 and caspase‐3 were observed in Western blot analyses. Our results demonstrated molecular mechanism of eugenol‐induced apoptosis in human colon cancer cells. This research will further enhance eugenol as a potential chemopreventive agent against colon cancer.

Tangible nanocomposites with diverse properties for heart valve application

Abstract Cardiovascular disease claims millions of lives every year throughout the world. Biomaterials are used widely for the treatment of this fatal disease. With the advent of nanotechnology, the use of nanocomposites has become almost inevitable in the field of biomaterials. The versatile properties of nanocomposites, such as improved durability and biocompatibility, make them an ideal choice for various biomedical applications. Among the various nanocomposites, polyhedral oligomeric silsesquioxane-poly(carbonate-urea)urethane, bacterial cellulose with polyvinyl alcohol, carbon nanotubes, graphene oxide and nano-hydroxyapatite nanocomposites have gained popularity as putative choices for biomaterials in cardiovascular applications owing to their superior properties. In this review, various studies performed utilizing these nanocomposites for improving the mechanical strength, anti-calcification potential and hemocompatibility of heart valves are reviewed and summarized. The primary motive of this work is to shed light on the emerging nanocomposites for heart valve applications. Furthermore, we aim to promote the prospects of these nanocomposites in the campaign against cardiovascular diseases.

Biomaterials in cardiovascular research: applications and clinical implications.

Cardiovascular biomaterials (CB) dominate the category of biomaterials based on the demand and investments in this field. This review article classifies the CB into three major classes, namely, metals, polymers, and biological materials and collates the information about the CB. Blood compatibility is one of the major criteria which limit the use of biomaterials for cardiovascular application. Several key players are associated with blood compatibility and they are discussed in this paper. To enhance the compatibility of the CB, several surface modification strategies were in use currently. Some recent applications of surface modification technology on the materials for cardiovascular devices were also discussed for better understanding. Finally, the current trend of the CB, endothelization of the cardiac implants and utilization of induced human pluripotent stem cells (ihPSCs), is also presented in this review. The field of CB is growing constantly and many new investigators and researchers are developing interest in this domain. This review will serve as a one stop arrangement to quickly grasp the basic research in the field of CB.

Effect of honey and eugenol on ehrlich ascites and solid carcinoma

Ehrlich ascites carcinoma is a spontaneous murine mammary adenocarcinoma adapted to ascites form and carried in outbred mice by serial intraperitoneal (i/p) passages. The previous work from our laboratory showed that honey having higher phenolic content was potent in inhibiting colon cancer cell proliferation. In this work, we extended our research to screen the antitumor activity of two selected honey samples and eugenol (one of the phenolic constituents of honey) against murine Ehrlich ascites and solid carcinoma models. Honey containing higher phenolic content was found to significantly inhibit the growth of Ehrlich ascites carcinoma as compared to other samples. When honey containing higher phenolic content was given at 25% (volume/volume) intraperitoneally (i/p), the maximum tumor growth inhibition was found to be 39.98%. However, honey was found to be less potent in inhibiting the growth of Ehrlich solid carcinoma. On the other hand, eugenol at a dose of 100 mg/kg i/p was able to inhibit the growth of Ehrlich ascites by 28.88%. In case of solid carcinoma, eugenol (100 mg/kg; i/p) showed 24.35% tumor growth inhibition. This work will promote the development of honey and eugenol as promising candidates in cancer chemoprevention.

Novel CuO/chitosan nanocomposite thin film: facile hand-picking recoverable, efficient and reusable heterogeneous photocatalyst

The present work demonstrates a new simple hand-picking technique for the 100% recovery of a photocatalyst. CuO nanospheres were synthesized by a simple wet chemical method and were subsequently embedded into the biopolymer matrix (chitosan) under mild conditions by the solution cast method and its photocatalytic application towards the degradation of organic pollutants was measured for the first time. The crystal structure, optical properties, surface and bulk morphology were discussed in detail. ICP-OES analysis showed 3.025% copper embedded in the chitosan (CS) matrix. Efficiency of the CuO/chitosan was evaluated against the degradation of rhodamine B dye as a probe. The combination of CuO nanospheres with chitosan leads to the higher efficiency of up to 99% degradation of the dye with 60 minutes of irradiation. This may be attributed to many features such as the slow electron hole pair recombination rate of nanosized CuO in the biopolymer matrix, the large surface area of the CuO and the high adsorption efficiency of the chitosan. The major advantage of this present protocol is that it is not only restricted to azo type dyes but can also be adopted for different kinds of organic pollutants. For all the types of organic contaminants tested, the CuO/chitosan nanocomposite thin film photocatalyst showed excellent activity. The facile hand-picking recovery and recyclability of this novel thin film likely opens up a new straightforward strategy in the effective photocatalytic degradation of organic contaminants.

Studies on the phenolic profiling, anti-oxidant and cytotoxic activity of Indian honey: in vitro evaluation

Commercial honey types were screened for phenolic profile and anti-oxidant capacity. Phenolic profiling was done using high performance liquid chromatography, which was further corroborated with electro spray ionisation-mass spectroscopy. Dihydroxy benzoic acid, caffeic acid, ferulic acid and cinnamic acid were the major phenolic constituents found in the honey samples. The anti-oxidant content and free-radical scavenging effect of honey were established using various assays. Total anti-oxidant potential and free-radical scavenging ability varied among the honey varieties and exhibited significant correlation with their phenolic content. Further, honey samples with richly abundant phenolic content were found to limit oxidant-induced cell death more effectively. Cytotoxic studies of a selected sample on a breast cancer cell displayed growth inhibition, depending on the concentration used. Cell cycle analysis indicated increasing accumulation of cells at the sub-G1 phase. These results summarise the phenolic profile and anti-oxidant and cytotoxic potential of Indian honey samples for the first time.

An insight on electrospun-nanofibers-inspired modern drug delivery system in the treatment of deadly cancers

In spite of ample researches and admirable achievements, there are still a significant number of deaths happening every year due to cancer. Furthermore, the number of new cases recorded is also not reduced despite the advent of various preventive measures. Though current clinical approaches yield commendable results, they elicit severe systemic side-effects and also fail to avoid the recurrence of the disease. To address these issues, nanotechnology-empowered modern drug delivery systems showcase excellent properties for the targeting and controlled delivery of biomolecules over a period of time. In the past decade, the materials-based cancer research field has witnessed the exploration of several attractive drug delivery approaches for the administration of synthetic drugs to genetic materials. Among those, the electrospinning-based nanofibrous mesh has attracted several works on treating common deadly cancers such as those of the lung, breast and colon. The capability of nanofibers to enable increased drug loading, maintenance of significant bioactivity, excellent drug encapsulation, controlled and targeted delivery, has helped the researchers to achieve successful administration of a variety of anti-cancer agents. This review gives an insight into the process of electrospinning, its essential parameters, the types of drug incorporation and the works reported on common deadly cancers. Moreover, the future direction of this effective alternative is also delineated, making electrospun nanofibers as a suitable vehicle for delivering drugs to the cancer sites.

Carbon nanotubes and graphene as emerging candidates in neuroregeneration and neurodrug delivery

Neuroregeneration is the regrowth or repair of nervous tissues, cells, or cell products involved in neurodegeneration and inflammatory diseases of the nervous system like Alzheimer’s disease and Parkinson’s disease. Nowadays, application of nanotechnology is commonly used in developing nanomedicines to advance pharmacokinetics and drug delivery exclusively for central nervous system pathologies. In addition, nanomedical advances are leading to therapies that disrupt disarranged protein aggregation in the central nervous system, deliver functional neuroprotective growth factors, and change the oxidative stress and excitotoxicity of affected neural tissues to regenerate the damaged neurons. Carbon nanotubes and graphene are allotropes of carbon that have been exploited by researchers because of their excellent physical properties and their ability to interface with neurons and neuronal circuits. This review describes the role of carbon nanotubes and graphene in neuroregeneration. In the future, it is hoped that the benefits of nanotechnologies will outweigh their risks, and that the next decade will present huge scope for developing and delivering technologies in the field of neuroscience.